SOLESENCE, INC. — Director's Dealing 2009

Oct 1, 2009

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NANOPHASE TECHNOLOGIES CORPORATION (NANX)
CIK: 0000883107
Period of Report: 2009-10-01

Reporting Person: PERKINS DONALD S (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2009-10-01	Stock Appreciation Right	$1.18	A	2750	Acquired		Common Stock (2750)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	48811	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$9.92	2011-06-05	Common Stock (2000)	2000	Direct
Stock Option (right to buy)	$3.78	2012-11-25	Common Stock (2000)	2000	Direct
Stock Option (right to buy)	$5.07	2013-06-26	Common Stock (2000)	2000	Direct
Stock Option (right to buy)	$3.13	2018-01-22	Common Stock (15000)	15000	Direct
Deferred Common Stock	$		Common Stock (2750)	24727	Direct

Footnotes

F1: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.

F2: Subject to certain restrictions, beginning on this date, options vest in two equal annual installments.

F3: Each share of deferred common stock represents a right to receive one share of common stock.

F4: The deferred common stock becomes payable upon the reporting person's termination of service as a director of the Company.

F5: Pursuant to such plan, the reporting person elected to defer receipt of such shares and receive a cumulative total of 24,727 shares of deferred common stock which will all be accounted for under the Company's Non-Employee Director Deferred Compensation Plan.

F6: The stock appreciation right becomes payable upon the reporting person's termination of service as a director of the Company. 2,750 were issued 4/8/2009 at a conversion price of $0.90, 2,750 were issued 7/1/2009 at a conversion price of $1.05, and 2,750 were issued 10/1/2009 at a conversion price of $1.18.